KLAS Contact
Contact KLAS
Contact KLAS
2024 BEST IN KLAS
Preferences
Related Series
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2008
2006
Clinical Market Share 2007
With ninety percent of acute care hospitals of 200+ beds having already contracted with a clinical information system (CIS), KLAS set out in this report to uncover how many are sticking with and how satisfied organizations are with their original decision.
Proof that CIS can and will be delivered as promised is a key toping of discussion at the executive level, along with concerns about clinical adoption, integration and overall cost. The demand for clinical access 24 hours a day, 365 days a year with acceptable end-user response times has layered the IT organization with deliverables never before required.
The report details scoring for the following products (Large – Over 200 Beds):
- Cerner Millennium PowerChart/PowerOrders/CareNet
- Eclipsys 7000 Series
- Eclipsys Sunrise Clinical Manager
- Eclipsys Sunrise Critical Care
- Epic EpicCare Inpatient
- GE Centricity Enterprise (Carecast)
- GE LastWord Clinicals (IDX)
- McKesson Horizon Expert Orders & Expert/Clinical Documentation
- McKesson STAR Clinicals
- Meditech C/S Enterprise Medical Record
- Meditech MAGIC Patient Care Inquiry
- Misys CPR
- QuadraMed Affinity Clinicals
- Siemens Soarian Clinicals
Early data is also available for CliniComp Essentris, CPSI Clinicals, McKesson Paragon Clinicals, Siemens MedSeries4 Clinicals and M2 Emphasis Clinical Information.
The report’s snapshot is immediately available. Summary and Final Reports will be available within a business day from purchase.
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.